Tranexamic acid (Leading BioSciences)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameTranexamic acid (Leading BioSciences)
Drug Alias NameInflammaGen Shok-PakLB-1148LB1148 (氨甲环酸)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen inhibitors
TargetsPlasminogen
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Post-surgical adhesionsIleus +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesLeading Biosciences IncHengyi Biomedical Technology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPalisade Bio IncLeading Biosciences IncJumpcan Pharmaceutical Group Co Ltd +[4] 
Inactive CompaniesNewsoara Biopharma Co Ltd
Active IndicationsPost-surgical adhesionsIntestinal Diseases
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)IleusIntestinal Obstruction +[5] 

Other Information

ATC CodeN/A
Related LinksN/A